Table 1.
Characteristics of the Patients.
| TKI (n = 71), n (%) | TKI + WE (n = 67), n (%) | P | |
|---|---|---|---|
| Age | 54 | 57 | >.05 |
| Gender | >.05 | ||
| Male | 20 (28.2%) | 21 (31.3%) | |
| Female | 51 (71.8%) | 46 (68.7%) | |
| Marital status | >.05 | ||
| Married | 63 (88.7%) | 62 (92.5%) | |
| Single | 1 (1.4%) | 0 | |
| Divorced | 4 (5.6%) | 3 (4.5%) | |
| Widowed | 3 (4.2%) | 2 (3.0%) | |
| ECOG performance | >.05 | ||
| 0 | 2 (2.8%) | 3 (4.5%) | |
| 1 | 4 (5.6%) | 6 (9.0%) | |
| 2 | 65 (91.6%) | 58 (86.5%) | |
| Brain metastases | 8 (11.3%) | 11 (16.4%) | >.05 |
| Initial anticancer therapy | >.05 | ||
| Oral EGFR-TKI | 71 | 67 | |
| Radiotherapy (brain) | 3 (4.2%) | 6 (9.0%) | |
| Smoking status | >.05 | ||
| Never smoked | 51 (71.8%) | 49 (73.1%) | |
| Smoking | 20 (28.2%) | 18 (26.9% | |
| HADS | 19.3 | 18.9 | >.05 |
| Stage of disease | >.05 | ||
| III | 22 (31.0%) | 15 (22.4%) | |
| IV | 49 (69.0%) | 52 (77.6%) | |
| Time since diagnosis | |||
| Within 1 month | 71 | 67 |
Abbreviations: TKI, tyrosine kinase inhibitor; WE, wellness education; ECOG, Eastern Cooperative Oncology Group functional status; EGFR, epidermal growth factor receptor; HADS, Hospital Anxiety and Depression Scale cutoff scores (0-7 = normal, 8-10 = borderline abnormal [borderline case]; 11-21 = abnormal).